Glenview State Bank Trust Department’s Bristol-Myers Squibb BMY Stock Holding History

Glenview State Bank Trust Department’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.97M	Sell	29,415 -770	-3%	-$50.2K	0.6%	40
2021 Q1	$1.91M	Buy	30,185 +370	+1%	+$23K	0.62%	38
2020 Q4	$1.85M	Buy	29,815 +885	+3%	+$54.4K	0.64%	36
2020 Q3	$1.74M	Sell	28,930 -35	-0.1%	-$2.11K	0.66%	35
2020 Q2	$1.7M	Sell	28,965 -40	-0.1%	-$2.39K	0.7%	33
2020 Q1	$1.62M	Sell	29,005 -200	-0.7%	-$12.2K	0.78%	34
2019 Q4	$1.87M	Buy	29,205 +17,380	+147%	+$995K	0.72%	35
2019 Q3	$600K	Hold	11,825	–	–	0.24%	66
2019 Q2	$536K	Hold	11,825	–	–	0.22%	67
2019 Q1	$564K	Hold	11,825	–	–	0.24%	66
2018 Q4	$615K	Buy	11,825 +800	+7%	+$43K	0.3%	60
2018 Q3	$684K	Hold	11,025	–	–	0.3%	59
2018 Q2	$610K	Sell	11,025 -100	-0.9%	-$5.4K	0.28%	61
2018 Q1	$704K	Hold	11,125	–	–	0.33%	55
2017 Q4	$682K	Buy	11,125 +425	+4%	+$26.6K	0.31%	57
2017 Q3	$682K	Sell	10,700 -4,000	-27%	-$234K	0.33%	54
2017 Q2	$819K	Sell	14,700 -700	-5%	-$38.1K	0.42%	45
2017 Q1	$837K	Hold	15,400	–	–	0.43%	45
2016 Q4	$900K	Hold	15,400	–	–	0.49%	43
2016 Q3	$830K	Sell	15,400 -162	-1%	-$10.4K	0.47%	46
2016 Q2	$1.14M	Sell	15,562 -100	-0.6%	-$7.07K	0.66%	40
2016 Q1	$1M	Sell	15,662 -2,400	-13%	-$151K	0.6%	43
2015 Q4	$1.24M	Buy	18,062 +462	+3%	+$30.5K	0.77%	37
2015 Q3	$1.04M	Sell	17,600 -3,800	-18%	-$241K	0.7%	39
2015 Q2	$1.42M	Sell	21,400 -3,700	-15%	-$244K	0.87%	34
2015 Q1	$1.62M	Sell	25,100 -200	-0.8%	-$12.5K	0.97%	29
2014 Q4	$1.49M	Sell	25,300 -1,700	-6%	-$95.9K	0.9%	32
2014 Q3	$1.38M	Sell	27,000 -1,300	-5%	-$64.9K	0.85%	36
2014 Q2	$1.37M	Hold	28,300	–	–	0.82%	36
2014 Q1	$1.47M	Sell	28,300 -2,387	-8%	-$127K	0.91%	34
2013 Q4	$1.63M	Buy	+30,687	New	+$1.56M	1.03%	30

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Glenview State Bank Trust Department's BMY Position: Q2 2021 in Review

Glenview State Bank Trust Department reduced its Bristol-Myers Squibb (BMY) stake by 2.6% in Q2 2021, selling an estimated $50.2K and leaving 29,415 shares worth $1.97M. The position accounts for 0.6% of the portfolio, ranked #40.

Glenview State Bank Trust Department first reported a position in BMY in Q4 2013 and has held it in 31 quarters since. 2,370 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Glenview State Bank Trust Department held 29,415 shares of Bristol-Myers Squibb worth $1.97M as of Q2 2021.
Glenview State Bank Trust Department sold 770 Bristol-Myers Squibb shares in Q2 2021, an estimated $50.2K.
Bristol-Myers Squibb made up 0.6% of Glenview State Bank Trust Department's portfolio in Q2 2021, its #40 holding.
Glenview State Bank Trust Department first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 31 quarters since.
2,370 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Glenview State Bank Trust Department's 13F filing for Q2 2021, filed 28 Jul 2021.